What prices were reported for Mark Hancock’s PACS share sales?

The filing reports weighted-average prices of $44.5582 and $44.9052 on September 14, 2026, and $42.0907, $42.8887, and $43.7485 on September 15, 2026, each covering multiple trades within stated price ranges.

Does the Form 4 show Mark Hancock’s remaining PACS share holdings?

No. For each reported transaction, the field for shares owned following the transaction is blank, so the Form 4 does not state Mark Hancock’s remaining PACS share holdings.

PACS director sells 300K shares in 10b5-1 plan

Q: How many PACS shares did Mark Hancock sell in this Form 4?

The Form 4 reports that Mark Hancock sold 300,000 shares of PACS Group, Inc. Common Stock in total, across multiple transactions on September 14 and 15, 2026.

Q: What is Mark Hancock’s relationship to PACS Group, Inc. in this Form 4?

Mark Hancock is identified as a director and a ten percent owner of PACS Group, Inc., making him an insider whose transactions must be reported on Form 4.

A PACS Group director and ten percent owner disclosed 300,000 PACS shares sold under a Rule 10b5-1 trading plan over two trading days.

Available on EDGAR 09/15/2026 - 06:01 PM EDT Accepted by SEC EDGAR 09/15/2026 - 06:00 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Very Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

PACS Group, Inc. (PACS) director and ten percent owner Mark Hancock reported open-market sales of 300,000 shares of Common Stock on September 14–15, 2026. The sales occurred in multiple transactions at weighted-average prices ranging from about $41.47 to $45.13 per share, and were effected under a Rule 10b5-1 trading plan adopted on March 11, 2026.

Insider Trade Summary 10b5-1

Net Seller: 300,000 shares

Net Sell 5 txns

Insider Hancock Mark

Role Director, 10% Owner

Sold 300,000 shs ($13.04M)

Share of Position Sold 0.56%

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F4}	104,132	$42.0907	$4.38M
Sale	Common Stock ^{F1, F5}	30,466	$42.8887	$1.31M
Sale	Common Stock ^{F1, F6}	21,084	$43.7485	$922K
Sale	Common Stock ^{F1, F2}	137,684	$44.5582	$6.13M
Sale	Common Stock ^{F1, F3}	6,634	$44.9052	$298K

Holdings After Transaction: Common Stock — 53,518,884 shares (Direct)

Holdings Before and After: Common Stock, 53,818,884 to 53,518,884 shares (Direct)

Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (6)

F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.
F2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.885 to $44.8845 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.885 to $45.13 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $41.47 to $42.465 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.47 to $43.4628 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.51 to $44.435 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 300,000 shares Shares sold September 14, 2026 (block 1): 137,684 shares Weighted-average price (block 1, Sept. 14): $44.5582 per share +5 more

8 metrics

Shares sold 300,000 shares Total Common Stock sales reported for September 14–15, 2026

Shares sold September 14, 2026 (block 1) 137,684 shares Common Stock sold at a weighted-average price on September 14, 2026

Weighted-average price (block 1, Sept. 14) $44.5582 per share Sold in multiple transactions within a $43.885–$44.8845 range

Shares sold September 14, 2026 (block 2) 6,634 shares Common Stock sold at a weighted-average price on September 14, 2026

Weighted-average price (block 2, Sept. 14) $44.9052 per share Sold in multiple transactions within a $44.885–$45.13 range

Shares sold September 15, 2026 (largest block) 104,132 shares Common Stock sold at a weighted-average price on September 15, 2026

Weighted-average price (largest block, Sept. 15) $42.0907 per share Sold in multiple transactions within a $41.47–$42.465 range

Rule 10b5-1 plan adoption date March 11, 2026 Date Hancock adopted the trading plan governing these sales

Key Terms

Rule 10b5-1 trading plan, weighted average price, multiple transactions, ten percent owner

4 terms

Rule 10b5-1 trading plan regulatory

"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

multiple transactions financial

"The securities were sold in multiple transactions at prices ranging"

ten percent owner regulatory

"Mark Hancock is identified as a director and ten percent owner"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PACS shares did Mark Hancock sell in this Form 4?

The Form 4 reports that Mark Hancock sold 300,000 shares of PACS Group, Inc. Common Stock in total, across multiple transactions on September 14 and 15, 2026.

On what dates were the PACS (PACS) insider sales by Mark Hancock executed?

The reported sales of PACS Common Stock by Mark Hancock were executed on September 14, 2026 and September 15, 2026, in multiple transactions on each date.

Were the PACS (PACS) insider sales made under a Rule 10b5-1 trading plan?

Yes. A footnote states that the sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mark Hancock on March 11, 2026.

What is Mark Hancock’s relationship to PACS Group, Inc. in this Form 4?

Mark Hancock is identified as a director and a ten percent owner of PACS Group, Inc., making him an insider whose transactions must be reported on Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hancock Mark

(Last)

(First)

(Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY

UTAH

84101

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/14/2026		S⁽¹⁾		137,684	D	$44.5582⁽²⁾	53,681,200	D
Common Stock	09/14/2026		S⁽¹⁾		6,634	D	$44.9052⁽³⁾	53,674,566	D
Common Stock	09/15/2026		S⁽¹⁾		104,132	D	$42.0907⁽⁴⁾	53,570,434	D
Common Stock	09/15/2026		S⁽¹⁾		30,466	D	$42.8887⁽⁵⁾	53,539,968	D
Common Stock	09/15/2026		S⁽¹⁾		21,084	D	$43.7485⁽⁶⁾	53,518,884	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.

2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.885 to $44.8845 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.885 to $45.13 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $41.47 to $42.465 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.47 to $43.4628 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.51 to $44.435 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR